fbpx

Cancer Research

61 results.

October 12, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

Studies to test whether epigenetic and immunotherapy combination therapies can extend survivorship in lung and bladder cancers GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research…

VAI DEFAULT HEADER
October 12, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…

June 13, 2017 VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers

International collaboration pairs immunotherapy with an epigenetic drug to stop progression of chronic myelomonocytic leukemia and myelodysplastic syndrome into acute myeloid leukemia GRAND RAPIDS, Mich.…

May 15, 2017 VARI cancer researcher elected to National Academy of Sciences

Stephen Baylin becomes third VARI-affiliated scientist to attain the distinction GRAND RAPIDS, Mich. (May 15, 2017) — Stephen Baylin, M.D., Director’s…

May 4, 2017 Research brief: Uncovering the mechanisms behind cancer metastasis

KEY TERMS Chromosomes: The X-shaped structure of a chromosome consists largely of tightly coiled DNA, which contains the genetic instruction manual. Without the packaging provided…

March 7, 2017 New drug combination targets aggressive blood cancer

Safety and efficacy of combining talazoparib with decitabine to treat acute myeloid leukemia (AML) are subject of multi-site clinical trial GRAND RAPIDS, Mich. (March 7,…

March 2, 2017 Three things to know about colorectal cancer

March marks Colorectal Cancer Awareness Month, a time to share information and raise awareness about these devastating diseases. Here are three key…